The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Needle-Free Drug Delivery Systems-Global Market Insights and Sales Trends 2024

Needle-Free Drug Delivery Systems-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1833012

No of Pages : 101

Ask Your Query
Synopsis
The global Needle-Free Drug Delivery Systems market size is expected to reach US$ 16720 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Needle-Free Drug Delivery Systems in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Needle-Free Drug Delivery Systems market. Jet-Based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Spring-Based segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle-Free Drug Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle-Free Drug Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle-Free Drug Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle-Free Drug Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle-Free Drug Delivery Systems covered in this report include Antares Pharma, Pharmajet, Optinose, Valeritas, Crossject, Injex Pharma, 3M Pharmaceuticals, Becton Dickinson (BD) and MedImmune, etc.
The global Needle-Free Drug Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix
Global Needle-Free Drug Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle-Free Drug Delivery Systems market, Segment by Type:
Jet-Based
Spring-Based
Laser-Based
Global Needle-Free Drug Delivery Systems market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Needle-Free Drug Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Needle-Free Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Needle-Free Drug Delivery Systems Market Overview
1.1 Needle-Free Drug Delivery Systems Product Overview
1.2 Needle-Free Drug Delivery Systems Market Segment by Type
1.2.1 Jet-Based
1.2.2 Spring-Based
1.2.3 Laser-Based
1.3 Global Needle-Free Drug Delivery Systems Market Size by Type
1.3.1 Global Needle-Free Drug Delivery Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Needle-Free Drug Delivery Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Needle-Free Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Needle-Free Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Needle-Free Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Needle-Free Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Needle-Free Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Needle-Free Drug Delivery Systems Sales Breakdown by Type (2018-2023)
2 Global Needle-Free Drug Delivery Systems Market Competition by Company
2.1 Global Top Players by Needle-Free Drug Delivery Systems Sales (2018-2023)
2.2 Global Top Players by Needle-Free Drug Delivery Systems Revenue (2018-2023)
2.3 Global Top Players by Needle-Free Drug Delivery Systems Price (2018-2023)
2.4 Global Top Manufacturers Needle-Free Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Needle-Free Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Needle-Free Drug Delivery Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Needle-Free Drug Delivery Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Needle-Free Drug Delivery Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Needle-Free Drug Delivery Systems Market
2.8 Key Manufacturers Needle-Free Drug Delivery Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Needle-Free Drug Delivery Systems Status and Outlook by Region
3.1 Global Needle-Free Drug Delivery Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Needle-Free Drug Delivery Systems Historic Market Size by Region
3.2.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Needle-Free Drug Delivery Systems Sales in Value by Region (2018-2023)
3.2.3 Global Needle-Free Drug Delivery Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Needle-Free Drug Delivery Systems Forecasted Market Size by Region
3.3.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Needle-Free Drug Delivery Systems Sales in Value by Region (2024-2029)
3.3.3 Global Needle-Free Drug Delivery Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Needle-Free Drug Delivery Systems by Application
4.1 Needle-Free Drug Delivery Systems Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Needle-Free Drug Delivery Systems Market Size by Application
4.2.1 Global Needle-Free Drug Delivery Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Needle-Free Drug Delivery Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Needle-Free Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Needle-Free Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Needle-Free Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Needle-Free Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Needle-Free Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Needle-Free Drug Delivery Systems Sales Breakdown by Application (2018-2023)
5 North America Needle-Free Drug Delivery Systems by Country
5.1 North America Needle-Free Drug Delivery Systems Historic Market Size by Country
5.1.1 North America Needle-Free Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Needle-Free Drug Delivery Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Needle-Free Drug Delivery Systems Sales in Value by Country (2018-2023)
5.2 North America Needle-Free Drug Delivery Systems Forecasted Market Size by Country
5.2.1 North America Needle-Free Drug Delivery Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Needle-Free Drug Delivery Systems Sales in Value by Country (2024-2029)
6 Europe Needle-Free Drug Delivery Systems by Country
6.1 Europe Needle-Free Drug Delivery Systems Historic Market Size by Country
6.1.1 Europe Needle-Free Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Needle-Free Drug Delivery Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Needle-Free Drug Delivery Systems Sales in Value by Country (2018-2023)
6.2 Europe Needle-Free Drug Delivery Systems Forecasted Market Size by Country
6.2.1 Europe Needle-Free Drug Delivery Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Needle-Free Drug Delivery Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Needle-Free Drug Delivery Systems by Region
7.1 Asia-Pacific Needle-Free Drug Delivery Systems Historic Market Size by Region
7.1.1 Asia-Pacific Needle-Free Drug Delivery Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Needle-Free Drug Delivery Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Needle-Free Drug Delivery Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Needle-Free Drug Delivery Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Needle-Free Drug Delivery Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Needle-Free Drug Delivery Systems Sales in Value by Region (2024-2029)
8 Latin America Needle-Free Drug Delivery Systems by Country
8.1 Latin America Needle-Free Drug Delivery Systems Historic Market Size by Country
8.1.1 Latin America Needle-Free Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Needle-Free Drug Delivery Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Needle-Free Drug Delivery Systems Sales in Value by Country (2018-2023)
8.2 Latin America Needle-Free Drug Delivery Systems Forecasted Market Size by Country
8.2.1 Latin America Needle-Free Drug Delivery Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Needle-Free Drug Delivery Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Needle-Free Drug Delivery Systems by Country
9.1 Middle East and Africa Needle-Free Drug Delivery Systems Historic Market Size by Country
9.1.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Needle-Free Drug Delivery Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Needle-Free Drug Delivery Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Needle-Free Drug Delivery Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Needle-Free Drug Delivery Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Antares Pharma
10.1.1 Antares Pharma Company Information
10.1.2 Antares Pharma Introduction and Business Overview
10.1.3 Antares Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Antares Pharma Needle-Free Drug Delivery Systems Products Offered
10.1.5 Antares Pharma Recent Development
10.2 Pharmajet
10.2.1 Pharmajet Company Information
10.2.2 Pharmajet Introduction and Business Overview
10.2.3 Pharmajet Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pharmajet Needle-Free Drug Delivery Systems Products Offered
10.2.5 Pharmajet Recent Development
10.3 Optinose
10.3.1 Optinose Company Information
10.3.2 Optinose Introduction and Business Overview
10.3.3 Optinose Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Optinose Needle-Free Drug Delivery Systems Products Offered
10.3.5 Optinose Recent Development
10.4 Valeritas
10.4.1 Valeritas Company Information
10.4.2 Valeritas Introduction and Business Overview
10.4.3 Valeritas Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Valeritas Needle-Free Drug Delivery Systems Products Offered
10.4.5 Valeritas Recent Development
10.5 Crossject
10.5.1 Crossject Company Information
10.5.2 Crossject Introduction and Business Overview
10.5.3 Crossject Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Crossject Needle-Free Drug Delivery Systems Products Offered
10.5.5 Crossject Recent Development
10.6 Injex Pharma
10.6.1 Injex Pharma Company Information
10.6.2 Injex Pharma Introduction and Business Overview
10.6.3 Injex Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Injex Pharma Needle-Free Drug Delivery Systems Products Offered
10.6.5 Injex Pharma Recent Development
10.7 3M Pharmaceuticals
10.7.1 3M Pharmaceuticals Company Information
10.7.2 3M Pharmaceuticals Introduction and Business Overview
10.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Products Offered
10.7.5 3M Pharmaceuticals Recent Development
10.8 Becton Dickinson (BD)
10.8.1 Becton Dickinson (BD) Company Information
10.8.2 Becton Dickinson (BD) Introduction and Business Overview
10.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Products Offered
10.8.5 Becton Dickinson (BD) Recent Development
10.9 MedImmune
10.9.1 MedImmune Company Information
10.9.2 MedImmune Introduction and Business Overview
10.9.3 MedImmune Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.9.4 MedImmune Needle-Free Drug Delivery Systems Products Offered
10.9.5 MedImmune Recent Development
10.10 Mystic Pharmaceuticals
10.10.1 Mystic Pharmaceuticals Company Information
10.10.2 Mystic Pharmaceuticals Introduction and Business Overview
10.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Products Offered
10.10.5 Mystic Pharmaceuticals Recent Development
10.11 Zogenix
10.11.1 Zogenix Company Information
10.11.2 Zogenix Introduction and Business Overview
10.11.3 Zogenix Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Zogenix Needle-Free Drug Delivery Systems Products Offered
10.11.5 Zogenix Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Needle-Free Drug Delivery Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Needle-Free Drug Delivery Systems Industrial Chain Analysis
11.4 Needle-Free Drug Delivery Systems Market Dynamics
11.4.1 Needle-Free Drug Delivery Systems Industry Trends
11.4.2 Needle-Free Drug Delivery Systems Market Drivers
11.4.3 Needle-Free Drug Delivery Systems Market Challenges
11.4.4 Needle-Free Drug Delivery Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Needle-Free Drug Delivery Systems Distributors
12.3 Needle-Free Drug Delivery Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock